All figures are in United States dollars unless otherwise stated. This news release contains forward-looking information that ...

The global biotechnology market was worth USD 1.68 trillion in 2024 and is expected to surge around USD 3.54 Trillion by 2033, with a noteworthy CAGR of 9.18% from 2024 to 2033. The growing demand for ...

Ultimately, though, a business plan will demonstratively prove why your business is a solid enough investment to risk ... each step of the way including templates that can be dropped in, and ...

AquaBounty GMO salmon was going to be the future of fish — and the future for one Ohio village that offered incentives to ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Qatar is an important and reliable partner in India’s energy security and, consequently, plays a significant role in India’s growth story ...

Genmab's Q4 2024 results impress with $897.4M revenue and 29% growth. GMAB's balance sheet is strong with nearly $3 billion ...

S&P has been able to leverage its moat to obtain solid pricing power, typically around 3%-4% per year. In 2025, S&P's rack rate for corporate finance ratings was 8.1 basis points, compared with 6.25 ...

Stay updated with a weekly recap covering market movements, economic insights, top news, and geopolitical events shaping the ...

We assign a Medium Morningstar Uncertainty Rating to Moody’s.

The Charlotte market is drawing new players in specialty coffee while existing concepts look to strengthen their footprint. The Charlotte market has become a mecca for specialty coffee. Mom-and-pop ...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to equity investors at the Whistler Capital Event conference, organized by ...